These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Taxol in bronchial carcinoma]. Gatzemeier U Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171 [No Abstract] [Full Text] [Related]
6. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712. Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR; J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656 [TBL] [Abstract][Full Text] [Related]
7. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study. Jeremić B; Milicić B; Acimović L; Milisavljević S J Clin Oncol; 2005 Oct; 23(28):6873-80. PubMed ID: 16192579 [TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial. Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655 [TBL] [Abstract][Full Text] [Related]
9. Docetaxel and non small-cell lung cancer: new indication. One of several non curative chemotherapies. Prescrire Int; 2001 Apr; 10(52):43-5. PubMed ID: 11718157 [TBL] [Abstract][Full Text] [Related]
10. Thoracic radiation therapy and concomitant low-dose daily paclitaxel in non-small cell lung cancer: a phase I study. Gobitti C; Franchin G; Minatel E; Gigante M; Basso B; Bujor L; Trovò MG Oncol Rep; 2005 Dec; 14(6):1647-53. PubMed ID: 16273271 [TBL] [Abstract][Full Text] [Related]
11. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer]. Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776 [TBL] [Abstract][Full Text] [Related]
12. Weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small cell lung cancer: phase I study. Endo M; Takada Y; Obayashi K; Kotani Y; Satouchi M; Kado T; Sugimura K Radiat Med; 2005 Aug; 23(5):331-5. PubMed ID: 16342905 [TBL] [Abstract][Full Text] [Related]
13. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study. Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450 [TBL] [Abstract][Full Text] [Related]
14. [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer]. Goldobenko GV; Kanaev SV Vopr Onkol; 1998; 44(5):623-8. PubMed ID: 9884730 [No Abstract] [Full Text] [Related]
15. [Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer or head and neck cancer]. Plasswilm L Strahlenther Onkol; 2000 Dec; 176(12):583-4. PubMed ID: 11140154 [No Abstract] [Full Text] [Related]
16. Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial. Stathopoulos GP; Katis C; Tsavdaridis D; Dimitroulis J; Karaindros D; Stathopoulos J; Dimou E Cancer Chemother Pharmacol; 2006 Oct; 58(4):555-60. PubMed ID: 16520987 [TBL] [Abstract][Full Text] [Related]
17. Dose fractionation and biological optimization in lung cancer. Trodella L; D'Angelillo RM; Ramella S; Ciresa M; Massaccesi M Rays; 2004; 29(3):319-26. PubMed ID: 15603304 [TBL] [Abstract][Full Text] [Related]